Raymond J. Henley Iii

Array ( [id] => 6538248 [patent_doc_number] => 20020193422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Anthranilamides and methods of their use' [patent_app_type] => new [patent_app_number] => 10/132184 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5482 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0193/20020193422.pdf [firstpage_image] =>[orig_patent_app_number] => 10132184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884671 [patent_doc_number] => 07351722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'Use of Mangafodipir for treating oxidative stress effects' [patent_app_type] => utility [patent_app_number] => 10/475555 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3400 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351722.pdf [firstpage_image] =>[orig_patent_app_number] => 10475555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1381464 [patent_doc_number] => 06555575 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-29 [patent_title] => 'Use of -tocopherol and its oxidative metabolite LLU- in the treatment of disease' [patent_app_type] => B2 [patent_app_number] => 10/134140 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14274 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555575.pdf [firstpage_image] =>[orig_patent_app_number] => 10134140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7474295 [patent_doc_number] => 20040122027 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-24 [patent_title] => 'Use of pyridoindolone derivatives for preparing anticancer medicines' [patent_app_type] => new [patent_app_number] => 10/476322 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1659 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20040122027.pdf [firstpage_image] =>[orig_patent_app_number] => 10476322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6653305 [patent_doc_number] => 20030008875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Use of regularly scheduled high dose intravenous methotrexate therapy, with interim administration of immunomodulatory agents, to treat multiple sclerosis and other diseases of the central nervous system' [patent_app_type] => new [patent_app_number] => 10/128947 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3483 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008875.pdf [firstpage_image] =>[orig_patent_app_number] => 10128947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575032 [patent_doc_number] => 06468965 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Pharmaceutical composition for oral administration of a mixture of chelating agents' [patent_app_type] => B1 [patent_app_number] => 10/127404 [patent_app_country] => US [patent_app_date] => 2002-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1426 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/468/06468965.pdf [firstpage_image] =>[orig_patent_app_number] => 10127404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1311706 [patent_doc_number] => 06613763 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Use of molindone to treat oppositional defiant disorder and conduct disorder' [patent_app_type] => B2 [patent_app_number] => 10/126065 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8138 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613763.pdf [firstpage_image] =>[orig_patent_app_number] => 10126065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1384528 [patent_doc_number] => 06552040 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-22 [patent_title] => 'Use of nitroxides in wound healing and in the prevention of photodamage' [patent_app_type] => B1 [patent_app_number] => 10/018301 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3933 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552040.pdf [firstpage_image] =>[orig_patent_app_number] => 10018301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6553390 [patent_doc_number] => 20020111356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Arylalkylpyridazinones' [patent_app_type] => new [patent_app_number] => 10/117217 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12395 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20020111356.pdf [firstpage_image] =>[orig_patent_app_number] => 10117217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818231 [patent_doc_number] => 20030069189 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Treatment of infarcts' [patent_app_type] => new [patent_app_number] => 10/118526 [patent_app_country] => US [patent_app_date] => 2002-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5317 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069189.pdf [firstpage_image] =>[orig_patent_app_number] => 10118526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6112582 [patent_doc_number] => 20020173466 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/114909 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5235 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20020173466.pdf [firstpage_image] =>[orig_patent_app_number] => 10114909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1370256 [patent_doc_number] => 06558666 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Chromium-containing carbohydrase enzyme food supplement composition' [patent_app_type] => B1 [patent_app_number] => 10/114042 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2949 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/558/06558666.pdf [firstpage_image] =>[orig_patent_app_number] => 10114042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089784 [patent_doc_number] => 20050009897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Method of treatment' [patent_app_type] => utility [patent_app_number] => 10/473667 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3889 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009897.pdf [firstpage_image] =>[orig_patent_app_number] => 10473667 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6684049 [patent_doc_number] => 20030119913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof' [patent_app_type] => new [patent_app_number] => 10/115266 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3821 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119913.pdf [firstpage_image] =>[orig_patent_app_number] => 10115266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7291285 [patent_doc_number] => 20040110784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Remedies for vesical stimulation association with prostatauxe' [patent_app_type] => new [patent_app_number] => 10/472148 [patent_app_country] => US [patent_app_date] => 2003-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7006 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110784.pdf [firstpage_image] =>[orig_patent_app_number] => 10472148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1246085 [patent_doc_number] => 06677374 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Nitrate esters and methods of making same' [patent_app_type] => B2 [patent_app_number] => 10/108513 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 18071 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677374.pdf [firstpage_image] =>[orig_patent_app_number] => 10108513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 418860 [patent_doc_number] => 07276532 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-02 [patent_title] => 'Remedies for vesical hyperactivity' [patent_app_type] => utility [patent_app_number] => 10/472143 [patent_app_country] => US [patent_app_date] => 2002-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7581 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/276/07276532.pdf [firstpage_image] =>[orig_patent_app_number] => 10472143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 982387 [patent_doc_number] => 06927231 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Use of creatine for the amelioration of oxidative stress' [patent_app_type] => utility [patent_app_number] => 10/473483 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2696 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/927/06927231.pdf [firstpage_image] =>[orig_patent_app_number] => 10473483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6047744 [patent_doc_number] => 20020168687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Inhibition of tau-tau-association' [patent_app_type] => new [patent_app_number] => 10/107181 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 16207 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168687.pdf [firstpage_image] =>[orig_patent_app_number] => 10107181 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241279 [patent_doc_number] => 06683102 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-27 [patent_title] => 'Methods of using metaxalone in the treatment of musculoskeletal conditions' [patent_app_type] => B2 [patent_app_number] => 10/104044 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2882 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683102.pdf [firstpage_image] =>[orig_patent_app_number] => 10104044 [rel_patent_id] =>[rel_patent_doc_number] =>)